Navigation Links
New Data Published in The Lancet Show GSK's ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
Date:11/23/2007

Protection Sustained During the First Two Years of Life

PHILADELPHIA, Nov. 23 /PRNewswire-FirstCall/ -- New data from a large European clinical trial published today in The Lancet show ROTARIX(R), GlaxoSmithKline's (NYSE: GSK) oral rotavirus candidate vaccine to prevent rotavirus gastroenteritis, provides protection against the five most commonly circulating rotavirus types around the world and in the United States (U.S.). The GSK candidate vaccine, if approved by the U.S. Food and Drug Administration (FDA), would enable completion of the rotavirus vaccination series by four months of age. Severe, dehydrating gastroenteritis occurs most commonly among children aged three to 35 months. Of children in the U.S. hospitalized with rotavirus, approximately one in five are younger than six months old.

Results from this multi-center, randomized, double-blind, placebo- controlled phase III clinical trial involving almost 4,000 European infants (candidate rotavirus vaccine n=2,572; placebo n=1,302) demonstrated that two doses of ROTARIX provided highly effective and sustained protection through two consecutive rotavirus seasons (approximately two years of age). The data show that, through two rotavirus seasons, the vaccine was highly efficacious against rotavirus hospitalizations (96%), severe rotavirus gastroenteritis (90%) and against rotavirus gastroenteritis of any severity (79%). Specifically, significant protection was demonstrated against severe rotavirus gastroenteritis caused by types G1 (96%), G2 (86%), G3 (94%), G4 (95%), and G9 (85%), the most commonly circulating rotavirus types around the world and in the United States.

"The candidate vaccine contains a live, weakened form of natural huma
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Actinobac Biomed, ... originally funded with investments from Foundation Venture Capital Group ... Bio International 2015 as part of the Start-Up Stadium ... FVCG President James M. Golubieski . ... biotechnology industry, will be held in Philadelphia ...
(Date:5/29/2015)... , May 29, 2015  The annual customer ... physicians ranks Praxis EMR as #1 across all specialties. ... Market Research LLC conducts a poll of EHR users ... the results.    Praxis EMR topped ... the 18 performance based criteria used by Black Book. ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
... Reportlinker.com announces that a new market research ... Gastric Cancer - Global Drug Forecasts and ... http://www.reportlinker.com/p0479813/Gastric-Cancer---Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-–-Volume-I-2011.html ... Analysis to 2020 – Volume I 2011 ...
... NEW YORK, April 12, 2011 Reportlinker.com announces that ... catalogue: Europe Nephrology and Urology Devices ... Europe Nephrology and Urology Devices Market ... GlobalData,s new report, "Europe Nephrology and Urology Devices ...
Cached Medicine Technology:Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 2Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 3Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 4Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 5Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 6Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 7Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 8Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 9Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 10Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 11Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 12Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 13Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 14Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 15Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 16Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 17Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 18Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 19Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 20Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 21Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 22Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 2Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 3Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 4Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 5Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 6Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 7Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 8Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 9Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 10Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 11Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 12Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 13Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 14Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 15
(Date:5/30/2015)... May 30, 2015 Venus Viva has ... scars, large pores, deep wrinkles, stretch marks, pigmentation irregularities, ... professional, such as Dr. F. Victor Rueckl of Lakes ... clinical trials in Las Vegas. This body image solution ... a system that delivers proven results through a skin ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
(Date:5/29/2015)... MO (PRWEB) May 29, 2015 Based in ... autism awareness shirts for a couple of months ... Their latest release, which reads “I’m not misbehaving, I ... worn by the parent’s of an autistic child in order ... of autism. , Not only are they raising awareness through ...
(Date:5/29/2015)... 2015 What does community do? , ... community comes together to plant gardens, to teach young ... awareness of critical issues. Community invites everyone to help ... , "What Community Does" was commissioned by The Denver ... and released during the foundation’s Annual Celebration in May. ...
(Date:5/29/2015)... M3 USA MDLinx.com, source of the ... specialties, now offers The Smartest Rheumatologist . The ... disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis and ... MDLinx, and Caroline Tredway, editorial head of The Smartest ... have on the physicians who participate. Says Tredway, “With ...
Breaking Medicine News(10 mins):Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2
... testing a candidate 2009 H1N1 influenza vaccine in pregnant ... Allergy and Infectious Diseases (NIAID), part of the National ... higher risk of developing severe illness if they become ... they are strongly encouraged to receive the seasonal influenza ...
... , , , ... Islands announced that the National Science Foundation (NSF) recently honored ... NSF Faculty Early Career Development (CAREER) award. , ... recognition of Gillespie,s teaching and research in protein-ligand interactions and ...
... to staph infections, researchers say , WEDNESDAY, Sept. 9 ... properties, might kill MRSA bacteria. , A new study ... honey, made solely from flowers found on the New ... protein, which is needed for fatty acid biosynthesis. The ...
... Tysabri appears to awaken dormant, common virus that crosses over ... may have discovered part of the reason why Tysabri, a ... development of a rare but potentially deadly brain disease in ... dormant JC virus from its slumber, allowing it to cross ...
... WASHINGTON, Sept. 9 Statement of Lisa A. Rickard, ... reports from White House press secretary Robert Gibbs that President ... Congress: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080919/USCHAMBERLOGO ... encouraged that President Obama understands the tremendous burden that medical ...
... , , HOFFMAN ESTATES, Ill., Sept. ... open tomorrow, Thursday, Sept. 10, and will continue through October 30, ... 900 Kmart Pharmacy locations for $25 while supplies last. ... your home for family health," says Robbert Ayshford, RPh, divisional vice ...
Cached Medicine News:Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:MRSA May Succumb to Honey 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 3
... next generation of the ultra-quiet ... III retains all the smooth, ... a leading name for,aspiration surgery ... pumps for high powered operation, ...
Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems...
... term being used today to describe the nature of ... may have been used in silicone implants in the ... not new technology cohesive is simply a word ... nature of the gel. All of Mentor silicone gel-filled ...
A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
Medicine Products: